All‐cause hospital mortality · participants with ST‐elevation myocardial infarction
Pre‐hospital showed no clear difference in all‐cause hospital mortality compared with in‐hospital thrombolysis (low certainty).
1 finding from 1 review
All‐cause mortality · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All‐cause mortality · people with cancer who have febrile neutropenia
Pre‐emptive antifungal therapy showed no clear difference in all‐cause mortality compared with empirical antifungal therapy (low certainty).
1 finding from 1 review
All‐cause mortality · solid organ transplant recipients with CMV viraemia
1 finding from 1 review
All‐cause mortality · Adult patients who required central venous catheters
Impregnated catheters showed no clear difference in all‐cause mortality compared with non‐impregnated catheters (high certainty).
1 finding from 1 review
All‐cause mortality · dialysis patients with depression
1 finding from 1 review
Mortality before hospital discharge · very preterm or very low birth weight infants
1 finding from 1 review
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Mortality (all‐cause) · people with cirrhosis and hepatorenal syndrome
It is very uncertain whether terlipressin changes mortality (All‐cause) compared with other vasoactive drugs (very low certainty).
1 finding from 1 review
RR 0.96 [0.88, 1.06]
474 participants
Very low
All‐cause mortality · people who underwent a lower limb revascularisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people who underwent a lower limb revascularisation
Duplex ultrasound plus pulse palpation and arterial pressure index… showed no clear difference in all‐cause mortality compared with pulse palpation plus arterial pressure index (ABI or TBI) (short term) (low certainty).
1 finding from 1 review
Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal death · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
All‐cause mortality (outcome collected through first event: death, hospital discharge, hospital transfer, or 120 days after birth) · preterm infants with or at risk of respiratory distress syndrome
Inositol supplementation IV initially followed by enteral… showed no clear difference in all‐cause mortality (outcome collected through first event: death,… compared with placebo (moderate certainty).
1 finding from 1 review
Mortality In the early postoperative period (≤ 30 days) · adult participants undergoing cardiac and major abdominal surgery
It is very uncertain whether preoperative inspiratory muscle training changes all‐cause mortality within 30 days during postoperative period compared with usual care, non‐exercise intervention (very low certainty).
1 finding from 1 review
Mortality before hospital discharge · preterm infants receiving nasal CPAP
Bubble showed no clear difference in all‐cause mortality before hospital discharge compared with ventilator or Infant Flow Driver nasal continuous positive airway… (low certainty).
1 finding from 1 review
All‐cause mortality ‐ after 24 months Number of participants: 287(2 RCTs)
It is very uncertain whether continuous positive airway pressure (CPAP) plus best supportive care changes all‐cause mortality ‐ after 24 months Number of participants: 287(2… compared with best supportive care (very low certainty).
1 finding from 1 review
RR 1.14 [0.83, 1.56]
Studies not reported
Very low
All‐cause mortality up to 30 days · hospitalised and unvaccinated individuals with a confirmed or suspected diagnosis of symptomatic COVID‐19
It is very uncertain whether summary of findings table ‐ Methylprednisolone changes all‐cause mortality up to 30 days compared with dexamethasone (very low certainty).
1 finding from 1 review
All‐cause mortality · pregnant women with fetal growth restriction
Sildenafil citrate showed no clear difference in all‐cause mortality compared with placebo or no therapy (moderate certainty).
1 finding from 1 review
All‐cause mortality · pregnant women with fetal growth restriction
1 finding from 1 review